Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study

Abstract Background Dexamethasone usually recommended for patients with severe coronavirus disease 2019 (COVID-19) to reduce short-term mortality. However, it is uncertain if another corticosteroid, such as methylprednisolone, may be utilized to obtain better clinical outcome. This study assessed de...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Daniah AlMohammady, Amjaad Alfahed, Elaf F. Altebainawi, Mohammed Aldhaeefi, Hisham A. Badreldin, Ramesh Vishwakarma, Faisal E. Almutairi, Abeer A. Alenazi, Thamer Alsulaiman, Rahaf Ali Alqahtani, Fahad Al Dhahri, Namareq Aldardeer, Ahmed O. Alenazi, Shmeylan Al Harbi, Raed Kensara, Mai Alalawi, Khalid Al Sulaiman
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2024-02-01
coleção:	BMC Infectious Diseases
Assuntos:	COVID-19 SARS-Cov-2 Dexamethasone Methylprednisolone Critically ill ICUs
Acesso em linha:	https://doi.org/10.1186/s12879-024-09056-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!